毒液免疫疗法：何时开始，何时停止。

Venom immunotherapy: when to start, when to stop.

作者信息

Graft D F

机构信息

Asthma and Allergic Diseases, Park Nicollet Clinic, Minneapolis, Minnesota 55416-2699, USA.

出版信息

Allergy Asthma Proc. 2000 Mar-Apr;21(2):113-6. doi: 10.2500/108854100778250897.

DOI:10.2500/108854100778250897

PMID:10791113

Abstract

Over the past 25 years, major advances have been made in the diagnosis and treatment of insect sting allergy. Controlled clinical trials have demonstrated the efficacy of venom immunotherapy (VIT) in the prevention of subsequent systemic reactions in allergic individuals. We have refined our criteria for selection of patients for VIT. Studies on selections of venoms, rush immunotherapy, and interval between VIT injections have been performed. Finally, much work has been done to try to define criteria for the discontinuation of VIT.

摘要

在过去25年里，昆虫叮咬过敏的诊断和治疗取得了重大进展。对照临床试验已证明毒液免疫疗法（VIT）在预防过敏个体后续全身反应方面的有效性。我们已经完善了VIT患者选择标准。开展了关于毒液选择、快速免疫疗法以及VIT注射间隔的研究。最后，为确定VIT停药标准做了大量工作。